Relay Therapeutics, Inc. SEC filings RLAY
Relay Therapeutics, Inc. has 556 filings in SEC EDGAR's recent list, going back to May 22, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| 424B5 | Prospectus supplement | May 21, 2026 | — |
| 424B5 | Prospectus supplement | May 19, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2025 | — |
| 424B5 | Prospectus supplement | Sep 11, 2024 | — |
| 424B5 | Prospectus supplement | Sep 9, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2024 | — |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 424B7 | Filing | Jan 10, 2024 | — |
| 424B7 | Filing | Nov 16, 2023 | — |
| S-8 | Employee stock plan registration | Feb 23, 2023 | — |
| 424B5 | Prospectus supplement | Sep 13, 2022 | — |
| 424B5 | Prospectus supplement | Sep 12, 2022 | — |
| 424B7 | Filing | Sep 1, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 424B5 | Prospectus supplement | Oct 13, 2021 | — |
| 424B5 | Prospectus supplement | Oct 12, 2021 | — |
| 424B7 | Filing | Aug 25, 2021 | — |
| 424B7 | Filing | Aug 13, 2021 | — |
| S-3ASR | Automatic shelf registration | Aug 12, 2021 | — |
| 424B4 | Prospectus | May 6, 2021 | — |
| S-1 | Registration statement | Apr 28, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| S-8 | Employee stock plan registration | Jul 17, 2020 | — |
| 424B4 | Prospectus | Jul 16, 2020 | — |
| S-1/A | Amended registration statement | Jul 15, 2020 | — |
| S-1/A | Amended registration statement | Jul 15, 2020 | — |
| S-1/A | Amended registration statement | Jul 14, 2020 | — |
| S-1/A | Amended registration statement | Jul 9, 2020 | — |
| S-1 | Registration statement | Jun 24, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RLAY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1812364
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.